Quantitative DNA analysis of an intracerebrally transplanted brain tumour model after experimental chemotherapy with BCNU and CCNU.
In the present study we investigated the susceptibility of high passages of the rat glial transplantation tumour G-XIII to chemotherapy using nitrosourea compounds. We observed a significant increase in lifespan (ILS) of animals treated with BCNU (37%, p < 0.01) and CCNU (27%, p < 0.01). There were no difference in the efficiency between these two substances. Using a semi-quantitative score system no histopathological changes were observed which were associated with the response to therapy. The only predicative parameter in the present study was the quantitative DNA distribution pattern. There was a close correlation between treatment and the occurrence of unimodal DNA distribution patterns indicating clonal regrowth of recurrent tumours. Moreover, we also observed a correlation of the DNA distribution pattern of recurrent tumours with the result of experimental chemotherapy. Survival times of animals suffering from tumours containing unimodal DNA histogram was significantly longer than survival times of rats with multimodal DNA distribution, i.e. bimodal or broad DNA histograms. A unimodal, near-diploid stem line was only present in treated animals suggesting that these clones are more resistant against therapy using nitrosourea compounds. Our data indicate DNA cytophotometry as comprehensive tool for the monitoring of therapy response and the design of experimental chemotherapy using rat glial tumours.
Schlegel
J
J
Department of Neuropathology, Philipps University, Marburg, Germany.
Stumm
G
G
Ruschoff
J
J
Mennel
H D
HD
D000818:Animals; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D016380:Brain Tissue Transplantation; D002330:Carmustine / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects; D003592:Cytophotometry; D004273:DNA, Neoplasm / Q000032:analysis*; D005910:Glioma / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D008130:Lomustine / Q000627:therapeutic use*; D009368:Neoplasm Transplantation; D051381:Rats; D011919:Rats, Inbred Strains; D014185:Transplantation, Isogeneic; D014407:Tumor Cells, Cultured
D004273:DNA, Neoplasm; D008130:Lomustine; D002330:Carmustine